Lercanidipine 10mg tablets

Држава: Велика Британија

Језик: Енглески

Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активни састојак:

Lercanidipine hydrochloride

Доступно од:

Recordati Pharmaceuticals Ltd

АТЦ код:

C08CA13

INN (Међународно име):

Lercanidipine hydrochloride

Дозирање:

10mg

Фармацеутски облик:

Oral tablet

Пут администрације:

Oral

Класа:

No Controlled Drug Status

Тип рецептора:

Valid as a prescribable product

Резиме производа:

BNF: 02060200; GTIN: 5060123270143

Информативни летак

LERCANIDIPINE HYDROCHLORIDE 10MG FILM-COATED TABLETS
PATIENT INFORMATION LEAFLET
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.
- If you get any side effects, talk to your doctor or pharmacist. This
includes
any possible side effects not listed in this leaflet.
Your medicine is called Lercanidipine hydrochloride 10mg film-coated
Tablets
but will be referred to as Lercanidipine hydrochloride throughout the
rest of
this leaflet. Please note that the leaflet also contains information
about the
other strength of medicine Lercanidipine hydrochloride 20mg
film-coated Tablets.
WHAT IS IN THIS LEAFLET:
What Lercanidipine hydrochloride is and what it is used for
What you need to know before you take Lercanidipine hydrochloride
How to take Lercanidipine hydrochloride
Possible side effects
How to store Lercanidipine hydrochloride
Contents of the pack and other information
WHAT LERCANIDIPINE HYDROCHLORIDE IS AND WHAT IT IS
USED FOR
Lercanidipine hydrochloride, belongs to a group of medicines called
Calcium
Channel Blockers (dihydropyridine derivatives) that lower blood
pressure.
Lercanidipine hydrochloride is used to treat high blood pressure also
known
as hypertension in adults over the age of 18 years (it is not
recommended
for children under 18 years old).
WHAT YOU NEED TO KNOW BEFORE YOU TAKE
LERCANIDIPINE HYDROCHLORIDE
Do not take Lercanidipine hydrochloride:
• If you are allergic (hypersensitive) to lercanidipine
hydrochloride or to any
other ingredients of Lercanidipine hydrochloride tablets.
• If you are suffering from certain heart diseases:
o obstruction to flow of blood from the heart
o untreated heart failure
o unstable angina (chest discomfort occurring at rest or pr

Карактеристике производа

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Lercanidipine HCl 10 mg film-coated tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 10 mg lercanidipine hydrochloride
(equivalent to
9.4 mg lercanidipine).
Excipient(s) with known effect:
One film-coated tablet contains 30 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
3
3
.
.
P
P
H
H
A
A
R
R
M
M
A
A
C
C
E
E
U
U
T
T
I
I
C
C
A
A
L
L
F
F
O
O
R
R
M
M
F
F
i
i
l
l
m
m
_-_
_-_
c
c
o
o
a
a
t
t
e
e
d
d
t
t
a
a
b
b
l
l
e
e
t
t
.
.
Y
Y
e
e
l
l
l
l
o
o
w
w
,
,
c
c
i
i
r
r
c
c
u
u
l
l
a
a
r
r
,
,
b
b
i
i
c
c
o
o
n
n
v
v
e
e
x
x
t
t
a
a
b
b
l
l
e
e
t
t
s
s
,
,
s
s
c
c
o
o
r
r
e
e
d
d
o
o
n
n
o
o
n
n
e
e
s
s
i
i
d
d
e
e
.
.
T
T
h
h
e
e
s
s
c
c
o
o
r
r
e
e
l
l
i
i
n
n
e
e
i
i
s
s
o
o
n
n
l
l
y
y
t
t
o
o
f
f
a
a
c
c
i
i
l
l
i
i
t
t
a
a
t
t
e
e
b
b
r
r
e
e
a
a
k
k
i
i
n
n
g
g
f
f
o
o
r
r
e
e
a
a
s
s
e
e
o
o
f
f
s
s
w
w
a
a
l
l
l
l
o
o
w
w
i
i
n
n
g
g
a
a
n
n
d
d
n
n
o
o
t
t
t
t
o
o
d
d
i
i
v
v
i
i
d
d
e
e
i
i
n
n
t
t
o
o
e
e
q
q
u
u
a
a
l
l
d
d
o
o
s
s
e
e
s
s
.
.
4
4
.
.
1
1
T
T
H
H
E
E
R
R
A
A
P
P
E
E
U
U
T
T
I
I
C
C
I
I
N
N
D
D
I
I
C
C
A
A
T
T
I
I
O
O
N
N
S
S
Lercanidipine HCl is indicated in adults for the treatment of mild to
moderate
essential hypertension
4
4
.
.
2
2
P
P
O
O
S
S
O
O
L
L
O
O
G
G
Y
Y
A
A
N
N
D
D
M
M
E
E
T
T
H
H
O
O
D
D
O
O
F
F
A
A
D
D
M
M
I
I
N
N
I
I
S
S
T
T
R
R
A
A
T
T
I
I
O
O
N
N
P
P
O
O
S
S
O
O
L
L
O
O
G
G
Y
Y
T
T
h
h
e
e
r
r
e
e
c
c
o
o
m
m
m
m
e
e
n
n
d
d
e
e
d
d
d
d
o
o
s
s
a
a
g
g
e
e
i
i
s
s
1
1
0
0
m
m
g
g
o
o
r
r
a
a
l
l
l
l
y
y
o
o
n
n
c
c
e
e
a
a
d
d
a
a
y
y
a
a
t
t
l
l
e
e
a
a
s
s
t
t
1
1
5
5
m
m
i
i
n
n
u
u
t
t
e
e
s
s
b
b
e
e
f
f
o
o
r
r
e
e
m
m
e
e
a
a
l
l
s
s
;
;
t
t
h
h
e
e
d
d
o
o
s
s
e
e
m
m
a
a
y
y
b
b
e
e
i
i
n
n
c
c
r
r
e
e
a
a
s
s
e
e
d
d
t
t
o
o
2
2
0
0
m
m
g
g
d
d
e
e
p
p
e
e
n
n
d
d
i
i
n
n
g
g
o
o
n
n
t
t
h
h
e
e
i
i
n
n
d
d
i
i
v
v
i
i
d
d
u
u
a
a
l
l
p
p
a
a
t
t
i
i
e
e
n
n
t
t
'
'
s
s
r
r
e
e
s
s
p
p
o
o
n
n
s
s
e
e
.
.
D
D
o
o
s
s
e
e
t
t
i
i
t
t